Palo Santo
Chicago, Illinoispalosanto.com
Overview
Palo Santo is a venture capital fund focused on emerging psychedelic medicines and therapies poised to address the growing mental health crisis and creating a new paradigm in wellbeing . The fund targets a diverse range of companies offering innovative solutions across biopharma, drug development, digital therapeutics, healthcare services and tech-enabled solutions to address the growing global mental health crisis . From cutting-edge science to commercial application, Palo Santo's portfolio includes 20+ companies focused on advancing the field of psychedelic medicines and expanding patient access and affordability .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Syndeio Biosciences | May 2025 | Series A | Co-investor |
| Xylo Bio | Jun 2024 | Seed | Co-investor |
| Journey Clinical | Jan 2023 | Series A | Co-investor |
| Sensorium Therapeutics | Nov 2022 | Series A | Co-investor |
| Fluence | Feb 2022 | Seed | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.